Detection of nitrosylated epitopes in Trypanosoma brucei gambiense by polyclonal and monoclonal anti-conjugated-NO-cysteine antibodies;Detection des epitopes nitrosyles dans les Trypanosoma brucei gambiense par des anticorps polyclonaux et monoclonaux anti-NO-cysteine conjuguee

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 322, Issue 4, 1999, Pages 311-322

  Mnaimneh, Sanié ^a,b,c   Geffard, Michel ^a   Veyret, Bernard ^a   Vincendeau, Philippe ^b  

^a CNRS   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c University College Station   (United States)

Author keywords

Activated macrophages; Antibodies; Infectious immunity parasites; Nitric oxide; Protozoan parasites

Indexed keywords

BCG VACCINE; CYSTEINE; EPITOPE; MONOCLONAL ANTIBODY; NITRIC OXIDE; NITROSO DERIVATIVE; PARASITE ANTIGEN; POLYCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; MACROPHAGE; NONHUMAN; TRYPANOSOMA BRUCEI;

ANIMALIA; MYCOBACTERIUM BOVIS BCG; ORYCTOLAGUS CUNICULUS; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA BRUCEI GAMBIENSE;

EID: 0033117096     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(99)80067-5     Document Type: Article

References (49)

1. Moncada S., Palmer R.M.J., Higgs E.A., Nitric oxide: Physiology, pathophysiology, and pharmacology, Pharmacol. Rev. 43 (1991) 109-142.
2. Nathan C., Xie Q.W., Regulation of biosynthesis of nitric oxide, J. Biol. Chem. 269 (1994) 13725-13728.
3. Albright J.W., Albright J.F., Differences in resistance to Typanosoma musculi infection among strains of inbred mice, Infect. Immun. 33 (1981) 364-371.
4. Blackwell J.M., Alexander J., The macrophage and parasitic protozoa, Trans. R. Soc. Trop. Med. Hyg. 77 (1983) 636-645.
5. Evans T.G., Thai L., Granger D.L., Hibbs J.B.H., Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 151 (1993) 907-915.
6. Lucas R., Magez S., De Leys R., Fransen L., Scheerlinck J.P., RampelBerg M., Sablon E., De Baetselie P., Mapping the lectin-like activity to tumor necrosis factor, Science 263 (1994) 814-817.
7. Mnaimneh S., Geffard M., Veyret B., Vincendeau P., Albumin nitrosylated macrophages posseses anti-parasitic effects neutralized by anti NO-cysteine antibodies, J. Immunol. 158 (1997) 308-314.
8. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Xu D., Muller W., Moncada S., Liew F.Y., Altered immune responses in mice lacking inducible nitric oxide synthase, Nature 375 (1995) 408-411.
9. Keaney J.F., Jr, Simon D.I., Stamler J.S., Jaraki O., Scharfstein J., Vita J.A., Loscalzo J., NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties, J. Clin. Invest. 91 (1993) 1582-1589.
10. Stamler J. S., Simon D.I., Jaraki O., Osborne J.A., Simon D.I., Keaney J., Vita J., Singel, D., Valeri C.R., Loscalzo J., Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin, Proc. Natl. Acad. Sci. (uSA) 89 (1992) 7674-7677.
11. 2 reaction, Chem. Res. Toxicol. 7 (1994) 519-525.
12. Harlow E., Lane D., Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1988, 84 pp.
13. Geffard M., Heinrich-Rock A.M., Dulluc J., Seguela P., Antisera against small neurotransmitter-like molecules, Neurochem. Int. 7 (1985a) 403-413.
14. Stamler J.S., Simon D.I., Jaraki O., Osborne J.A., Francis S., Mullins M., Singel D., Lascalso J., S-nitrosylation of tissue-type plasminogen activator confers vasodilatatory and antiplatelet type plasminogen activator confers vasodilatary and antiplatelet properties on the enzyme, Proc. Natl. Acad. Sci. (uSA) 89 (1992) 8087-8091.
15. Geffard M., Buijs R.M., Seguela P., Pool C.W., Le Moal M., First demonstration of highly specific and sensitive antibodies against dopamine, Brain Res. 294 (1984) 161-165.
16. Geffard M., Mc Rae-Degueurce A., Souan M.L., Immunocytochemical detection of acetylcholine in the rat central nervous system, Science 229 (1985) 77-79.
17. Campistron G., Geffard M., Buijs R., Immunological approch to the detection of taurine and immunocytochemical results, J. NeuroChem. 46 (1986) 862-868.
18. Engvall E., Perlmann P., Enzyme-linked immunosorbent assay, LISA: Quantitation of specific antibodies by enzyme-labelled anti-immunoglobulin in antigen-coated tubes, J. Immunol. 109 (1972) 129-135.
19. Geffard M., Seguela P., Henrich-Rock A.M., Antisera against cate-cholamines: Specificity studies and physicochemical data for anti-dopamine and anti-p-tyramine antibodies, Mol. Immunol. 21 (1984), 515-522.
20. Chagnaud J.L., Mons N., Tuffet S., Grander-Vazeille X., Geffard M., Monoclonal antibodies against glutaraldehyde conjugated dopamine, J. Neurochem. 49 (1987) 487-497.
21. Chagnaud J.L., Campistron G., Geffard M., Monoclonal antibody directed against glutaraldehyde-conjugated glutamate and immunocytochemical applications in the rat brain, Brain Res. 481 (1989) 175-180.
22. Chagnaud J.L., Souan M.L., Charrier M.C., Geffard M., Monoclonal anti-conjugated acetylcholine antibody and immunohistochemical applications in rat nervous system, J. Neurochem. 53 (1989), 383-391.
23. Chagnaud J.L., Gosset I., Brochet B., Audhuy S., Geffard M., Monoclonal anti-conjugated azelaic acid antibody production application to multiple sclerosis, Neuroreport 1 (1990) 141-145.
24. Vincendeau P., Daulouède S., Veyret B., Darde M.L., Bouteille B., Lemersre J.L., Nitric oxide mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei, Exp. Parasitol. 75 (1992) 353-360.
25. Mnaimneh S., RéAlisation Et PropriéTés D'anticorps DirigéS Contre Des ÉPitopes NitrosyléS, thèse, université de Bordeaux-II, 1996, p. 24, 51.
26. Vincendeau P., Daeron M., Trypanosoma musculi co-express several receptors binding rodent IgM, IgE, and IgG subclasses, J. Immunol. 142 (1989) 1702-1709.
27. Albright J.W., Albright J.F., In vitro growth of Trypanosoma musculi in cell free medium conditionned by rodent macrophages and mercaptoethanol, Int. J. Parasitol. 10 (1980) 137-142.
28. Hirumi H., Hirumi K., Continuous cultivation of Trypanosoma brucei bloodstream forms in a medium containing a low concentration of serum protein without feeder cell layers, J. Parasitol. 75 (1989) 985-989.
29. Oka M., Yoshisada Y., Ito Y., Takayanagi T., Polyclonal B-cell stimulative and immunosuppressive activities at different developmental stages of Trypanosoma gambiense, Microbiol. Immunol. 32 (1988) 1175-1177.
30. Vincendeau P., Guilleman B., Daulouède S., Ripert C., In vitro growth of trypanosoma musculi, Int. J. Parasitol. 16 (1985) 387-390.
31. Harlow E., Lane D., Attaching suspension cells to slides using the cytocentrifuge. Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1988, 371 p.
32. Lepoivre M., Boudbib F., Petit J.F., Antiproliferatif activity of interferon combined with lipopolisaccharide on murine adenocarcinoma: Dependence on an L-arginine metabolism with production of nitrite and citrulline, Cancer Res. 49 (1989) 1970-1976.
33. Yu W.G., Yamamoto N., Takenaka H., Mu J., Tai X.G., Zou J.P., Ogawa M., Tsutsui T., Wijesuriya R., Yoshida R., Herrmann S., Fujiwara H., Hamaoka T., Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12, Int. Immunol. 8 (1996) 855-865.
34. Abe K., Harada M., Tamada K., Ito O., Li T.L., Nomoto K., Early-appearing tumor-infiltrating natural killer cells play an important role in the nitric oxide production of tumor-associated macrophages through their interferon production, Cancer Immunol. Immunother. 45 (1998) 225-233.
35. Norris K.A., Schrimpf J.E., Flynn J.L., Morris Jr. S.M., Enhancement of macrophage microbicidal activity: Supplemental arginine and citrulline augment nitric oxide production in murine peritoneal macrophages and promote intracellular killing of Trypanosoma cruzi, Infect. Immun. 63 (1995) 2793-2796.
36. Fernandez-Gomez R., Esteban S., Gomez-Corvera R., Zoulika K., Ouaissi A., Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages, J. Immunol. 160 (1998) 3471-3479.
37. Jacobs F., Chaussabel D., Truyens C, Leclerq V., Carlier Y., GoldMan M., Vray B., IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: Improved control of Trypanosoma cruzi infection, Clin. Exp. Immunol. 113 (1998) 59-64.
38. Daulouède S., Okomo-Assoumou M.-C., Labassa M., Fouquet Ch., Vincendeau, P., Mécanisme de défense au cours des trypanosomoses, Bull. Soc. Path. Ex. 87 (1994) 330-332.
39. Vincendeau P., Daulouède S., Macrophage cytostatic effect on Trypanosoma musculi involves an L-arginine-dependent mechanism, J. Immunol. 146 (1991) 4338-4343.
40. Collins J.M., Klecker R.W., Yarchoan R., Clifford Lane H., Fauci A.S., Redfeild R.R., Broder S., Myers C., Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection, J. Clin. Pharmacol. 26 (1986) 22-26.
41. Lopez R.L., Peters G.J., Van Loenen A.C., Pizao P.E., Van Rijswijk R.E.N., Wagstaff J., Pinedo H.M., The effect of schedule, protein binding and growth factors on the activity of suramin, Int. J. Cancer 51 (1992) 921-926.
42. Vansterkenburg E.L.M., Wilting J., Janssen L.H.M., Influence of pH on the binding of suramin to human serum albumin, Biochem. Pharmacol. 38 (1989) 3029-3035.
43. Scharfstein J.S., Keaney Jr. J.F., Slivka A., Welch G.N., Vita J.A., Stamler J.S., Loscalzo J., In vivo transfert of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols, J. Clin. Invest. 94 (1994) 1432-1439.
44. Ignarro L.J., Lipton H., Edward J.C., Barricos W.H., Hyman A.L., Kodowitz P.J., Greutter C.A., Mechanism of vascular smooth muscle relaxation by organic nitrates, sodium nitroprusside, and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates, J. Pharmacol. Exp. Ther. 218 (1981) 739-749.
45. Ignarro L.J., Biological actions and properties of endothelium derived nitric oxide formed and released from artery and vein, Circ. Res. 65 (1989) 1-21.
46. Kelm M., Schrader J., Control of coronary vascular tone by nitric oxide, Circ. Res. 66 (1990) 1561-1575.
47. Stamler J.S., Simon D.I., Osborne J.A., Mullins M., Jaraki O., Michel T., Singel D., Lascalso J., S-nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds, Proc. Natl. Acad. Sci. (uSA) 89 (1992) 444-448.
48. Drapier J.C., Hibbs J.B., Murine cytotoxic activated macrophages inhibit aconitase in tumor cells, J. Clin. Invest. 78 (1986) 790-797.
49. Lemesre J.L., Senero D., Daulouède S., Veyret B., Brajon N., Vincendeau P., Leisbmania spp.: Nitric oxide-mediated metabolic inhibition of promastogote and axenically grown amastigote forms, Exp. Parasitol. 86 (1997), 58-68.